-
The identification of artefacts in reporting of drug‐induced deaths using structural breaks analysis of time series statistics Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-04-20 Benjamin Petruželka, Viktor Mravčík, Miroslav BartÁk, Thomas F. Babor
Drug‐related mortality is a key epidemiological indicator that is collected nationally and internationally. Significant efforts were made in 2006–2007 to improve the quality of data concerning drug‐related mortality in the Czech Republic. The aim of this article is to identify the effect of a quality improvement project on the drug‐induced mortality data reported in the General Mortality Registry (GMR)
-
Effects of self‐control, drug‐use peers and family attachment on drug use among Chinese users: A gender‐specific analysis Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-04-15 Serena Yunran Zhang, Jakob Demant
The increasing trend of synthetic drug use has been a significant concern in China. The current research adopted a gendered perspective to examine the effects of self‐control, drug‐use peers and family attachment on drug use frequency in China.
-
Validation of the French version of the Cannabis Use Disorder Identification Test—Revised and comparison with the Cannabis Abuse Screening Test for screening cannabis use disorder in a psychiatric sample Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-04-14 Amandine Luquiens, Aurélie Berger‐Viergat, Agathe Larrieu, Laura Artigaud, Clémentine Fener, Simon Adamson, Vincent Laprévote, Benjamin Rolland
Several questionnaires have been developed for screening cannabis use disorder in clinical populations, but very few studies have compared the screening abilities of the different instruments. Here, we aimed to confirm the psychometric properties of a French version of the Cannabis Use Disorder Identification Test—Revised (CUDIT‐R), and to compare its screening abilities with those of the Cannabis
-
The role of cannabis in pain management among people living with HIV who use drugs: A qualitative study Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-04-11 Koharu Loulou Chayama, Jenna Valleriani, Cara Ng, Rebecca Haines‐Saah, Rielle Capler, M.‐J. Milloy, Will Small, Ryan McNeil
People living with HIV who use drugs commonly experience chronic pain and often use illicit opioids to manage pain. Recent research suggests people living with HIV use cannabis for pain relief, including as an adjunct to opioids. This underscores the need to better understand how people living with HIV who use drugs use cannabis for pain management, particularly as cannabis markets are undergoing changes
-
‘Money up in smoke’: The financial benefits of smoking cessation may be more motivating to people who are homeless than potential health gains Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-04-07 Cheneal Puljević, Aaron Snoswell, Lorena Rivas, Mohammed M. Ali, Wouter de Greef, Jason Ferris, Coral Gartner
High rates of tobacco smoking among people who are homeless or living in temporary accommodation exacerbate poor health outcomes and financial disadvantage. There is limited research on this population's perceptions of smoking cessation benefits or support strategies.
-
The effectiveness of technology‐based interventions for smoking cessation: An umbrella review and quality assessment of systematic reviews Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-04-06 Amanual Getnet Mersha, Michelle Bovill, Parivash Eftekhari, Daniel Asfaw Erku, Gillian S. Gould
With the advancement and rapid increase in the public's interest in utilisation of Internet and mobile phones, technology‐based interventions are being implemented across a range of health conditions to improve patient outcomes. The aim of this review was to summarise findings from systematic reviews that evaluated the effectiveness of technology‐based smoking cessation interventions and to critically
-
Exploiting motherhood: Do mummy drinking sites offer real support or are they mainly alcohol marketing? Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-04-05 Linda M. Bosma, Norman Giesbrecht, Anne‐Marie Laslett
Even as women's roles have expanded substantially beyond traditional sex stereotypes, women are still commonly portrayed as uncomplaining caregivers, long‐suffering intimate partners and in control of family matters, all while maintaining a sexualised femininity. Nowhere are these stereotypes and expectations more apparent than for mothers. However, some social media are exploiting mothers by inappropriately
-
Increasing compliance with alcohol service laws in community sporting clubs in Australia Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-04-05 Peter Kremer, Nicholas Crooks, Bosco Rowland, Jessica Hall, John W. Toumbourou
Many community sporting clubs in Australia sell alcohol, but many do not comply with laws that require verification of age and forbid underage alcohol sales. This study aimed to assess the effectiveness of an intervention that incorporated sales monitoring and community awareness raising to improve compliance with alcohol service regulations in community sporting clubs.
-
The role of alcohol use in the aetiology and progression of liver disease: A narrative review and a quantification Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-30 Jürgen Rehm, Jayadeep Patra, Alan Brennan, Charlotte Buckley, Thomas K. Greenfield, William C. Kerr, Jakob Manthey, Robin C. Purshouse, Pol Rovira, Paul A. Shuper, Kevin D. Shield
Alcohol use has been shown to impact on various forms of liver disease, not restricted to alcoholic liver disease.
-
Advancing the science on cannabis concentrates and behavioural health Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-30 L. Cinnamon Bidwell, Renée Martin‐Willett, Hollis C. Karoly
The Cannabis sativa L. plant contains hundreds of phytocannabinoids, but putatively of highest importance to public health risk is the psychoactive cannabinoid delta‐9‐tetrahydrocannabinol (THC), which is associated with risk for cannabis use disorder, affective disturbance, cognitive harm and psychomotor impairment. Recently, there has been an increase in the use and availability of concentrated cannabis
-
Feasibility and pilot efficacy of cognitive remediation for people in residential substance use treatment Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-29 Julaine Allan, Anna Thompson, Molly Carlyle, Matthew Thomas, Alice Medalia
There are high rates of cognitive impairment among people seeking treatment for problematic substance use, which is rarely addressed in treatment programs. The aim of this pilot study was to evaluate the feasibility and outcomes of the neuropsychological and educational approach to cognitive remediation (NEAR) in a residential substance treatment setting.
-
New Zealand roll‐your‐own smokers' reaction to novel roll‐your‐own tobacco packaging warning labels Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-28 Mei‐Ling Blank, Janet Hoek, Philip Gendall
Although roll‐your‐own (RYO) loose tobacco is increasingly popular among smokers, no jurisdictions have used RYO‐specific pictorial warning labels (PWL) on tobacco packaging. We explored how New Zealand RYO smokers, a population with over 10 years of exposure to PWLs, reacted to RYO‐specific warnings featuring novel themes.
-
Alcohol and other drug health‐care providers and their client's perceptions of e‐cigarette use, safety and harm reduction Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-28 Eliza Skelton, Ashleigh Guillaumier, Flora Tzelepis, Scott Walsberger, Christine L. Paul, Adrian J. Dunlop, Kerrin Palazzi, Billie Bonevski
E‐cigarettes containing nicotine may potentially assist cessation in a heavily nicotine‐dependent population with high relapse and tobacco‐related burden. This study aims to determine alcohol and other drug (AOD) health‐care provider and client awareness, use and attitudes regarding harm reduction and safety of e‐cigarettes.
-
The geographic distribution of retail tobacco outlets in Yogyakarta, Indonesia Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-28 Christopher N. Morrison, Juliet P. Lee, Daniel P. Giovenco, Brooke West, Irma Hidayana, Putu A. S. Astuti, Stephen J. Mooney, Ahuva Jacobowitz, Andrew Rundle
Tobacco smoking prevalence in Indonesia is among the highest in the world. Research worldwide identifies that physical access to tobacco through retail outlets is related to increased tobacco smoking. Tobacco outlet density is very high in many Indonesian cities, so tobacco access may contribute to the high prevalence of tobacco use in that country. The aim of this study was to examine distributions
-
Understanding non‐installers of the ignition interlock device: A qualitative analysis Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-25 Ann M. Romosz, Michael Scherer, Robert B. Voas, Eduardo Romano, Thomas H. Nochajski, Eileen P. Taylor, Meg R. Brogdale, Amy R. Manning
Literature notes the efficacious use of alcohol ignition interlock devices (IID) in reducing rates of drinking and driving while installed on the vehicle. Some drivers who are convicted of driving while intoxicated (DWI) elect to have their license suspended/revoked instead of installing the device. These individuals represent a high‐risk subsample of drivers, yet limited literature has addressed this
-
The alcohol advertising ban in Norway: Effects on recorded alcohol sales Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-24 Ingeborg Rossow
Although bans or restrictions on alcohol advertising are recommended as one of the three most effective and cost‐effective policies to curb alcohol consumption, the best evidence to support this is indirect. The aim of this study was to examine whether the complete ban on alcohol advertising in Norway in 1975 had any effect on total alcohol sales.
-
Concordance between self‐reported and current hepatitis C virus infection status in a sample of people who inject drugs in Sydney and Canberra, Australia Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-23 Daisy Gibbs, Jason Grebely, Rachel Sutherland, Sarah Larney, Kerryn Butler, Paul M. Dietze, Mitchell Starr, Amy Peacock
Awareness of hepatitis C virus (HCV) status among people who inject drugs is critical to ensure linkage to care and reduce transmission risk. Testing pathways, confusion about results and possible reinfection raise potential for discordance between perceived and actual HCV status among people who inject drugs. We evaluated self‐reported and serologically confirmed HCV status concordance among a sample
-
The non‐government alcohol and other drug workforce in Australia: Findings from a national survey Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-16 Ann M. Roche, Natalie Skinner
There is growing interest in the role of the non‐government sector in the alcohol and other drug (AOD) service delivery system. This study examined the demographic profile of AOD workers in the non‐government (NGO) compared to government sector, to ascertain their professional development needs, job satisfaction, retention and turnover.
-
Quantifying nicotine and alcohol consumption in New Zealand using wastewater‐based epidemiology timed to coincide with census Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-14 Sam Trowsdale, Mackay Price, Chris Wilkins, Ben Tscharke, Jochen Mueller, Tom Baker
Accurate and timely information about nicotine and alcohol consumption is needed to inform effective policy. Wastewater‐based epidemiology provides an opportunity to quantify consumption, which can complement traditional data collection methods.
-
Trends in adolescent alcohol and other risky health‐ and school‐related behaviours and outcomes in Australia Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-14 Rakhi Vashishtha, Amy Pennay, Paul M. Dietze, Michael Livingston
Adolescent drinking has been declining in Australia over the past two decades, but this trend may be part of a broader shift towards healthier lifestyles for adolescents. We examined trends in the prevalence of multiple risky health‐ and school‐related behaviours and outcomes to test whether this was the case.
-
Alcohol and cocaine use prior to suspected suicide: Insights from toxicology Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-14 James Bailey, Nicola J. Kalk, Rebecca Andrews, Sarah Yates, Limon Nahar, Michael Kelleher, Susan Paterson
This study investigates whether there is a relationship between alcohol and cocaine use in deaths where suicide by self‐injury is the suspected cause of death.
-
Attitudinal factors associated with drink counting Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-14 Leon Booth, Michelle I. Jongenelis, Catherine Drane, Peter G. Miller, Tanya Chikritzhs, Penelope Hasking, Gerard Hastings, Michael Thorn, Simone Pettigrew
‘Count your drinks’ is a protective behavioural strategy (PBS) that has been found to be effective in reducing alcohol consumption. Previous research has shown that females, older people and low‐risk drinkers are more likely to use this strategy, but little is known about the attitudinal factors associated with engaging in drink counting. This information is important for developing effective interventions
-
Effects of stomach content on the breath alcohol concentration‐transdermal alcohol concentration relationship Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-12 Emily B. Saldich, Chunming Wang, I. Gary Rosen, Jay Bartroff, Susan E. Luczak
Wearable devices that obtain transdermal alcohol concentration (TAC) could become valuable research tools for monitoring alcohol consumption levels in naturalistic environments if the TAC they produce could be converted into quantitatively‐meaningful estimates of breath alcohol concentration (eBrAC). Our team has developed mathematical models to produce eBrAC from TAC, but it is not yet clear how a
-
A multi‐methods yarn about SMART Recovery: First insights from Australian Aboriginal facilitators and group members Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-08 Elizabeth Dale, K. S. Kylie Lee, Katherine M. Conigrave, James H. Conigrave, Rowena Ivers, Kathleen Clapham, Peter J. Kelly
SMART Recovery is a popular mutual support group program. Little is known about its suitability or perceived helpfulness for Indigenous peoples. This study explored the cultural utility of SMART Recovery in an Australian Aboriginal context.
-
Impact of body mass and alcohol consumption on all‐cause and liver mortality in 240 000 adults in the United States Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-08 Jayadeep Patra, Charlotte Buckley, William C. Kerr, Alan Brennan, Robin C. Purshouse, Jürgen Rehm
Nationally representative studies of the combined impact of drinking and body mass (BMI) on mortality outcomes are unavailable. We investigate whether both act together to elevate risk of all‐cause or liver mortality.
-
Costing alcohol‐related assault in the night‐time economy from a societal perspective: The case of Central Sydney Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-02-25 Simon Deeming, Kypros Kypri
There is a concern in many countries about violence from late‐night alcohol sales and appropriate regulatory responses. However, economic losses arising from this activity rarely feature in public debate. Credible estimates are lacking because economic evaluations have not taken a ‘societal perspective’, costing health, policing and criminal justice outcomes. Our aims were to: (i) develop an analytic
-
Why did New Zealand's referendum to legalise recreational cannabis fail? Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-07 Marta Rychert, Chris Wilkins
New Zealand recently held the world's first national referendum on cannabis legalisation involving a detailed bill to regulate retail sale and supply of cannabis for recreational (non‐medical) adult use (i.e. the Cannabis Legalisation and Control Bill; CLCB). The referendum generated significant domestic debate and lobbying from both sides of the issue. The CLCB was narrowly defeated, with 48.4% voting
-
Using social media comments to reduce alcohol purchase intentions: An online experiment Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-07 Jonathan K. Noel
Alcohol advertising is prevalent on social media. The current study sought to identify effective message types to pair with social media alcohol ads to minimise purchase intentions associated with exposure.
-
Could a drug‐checking service increase intention to use ecstasy at a festival? Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-07 Sherri Murphy, Stephen J. Bright, Greg Dear
Calls to provide sanctioned drug‐checking (pill testing) at Australian music festivals have been met with resistance from most governments due to concerns that such services would increase use of ecstasy and other drugs. We investigated that concern and used the Theory of Planned Behaviour to examine the determinants of intention to use a drug‐checking service.
-
Heterogeneity in trends of alcohol use around the world: Do policies make a difference? Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-02-03 Jürgen Rehm, Thomas F. Babor, Sally Casswell, Robin Room
In this issue of Drug and Alcohol Review, in a section entitled ‘Alcohol trends and policies in the wider world – beyond a Eurocentric view’, four overview papers are presented [1-4], which describe regional trends in alcohol use, attributable harm and policy. These papers are part of an effort to expand the base of epidemiological data and policy experience beyond the high‐income countries so that
-
Comprehensive analysis of alcohol policies in the Latin America and the Caribbean Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-01-24 María Elena Medina‐Mora, Maristela Monteiro, Claudia Rafful, Itzel Samano
The aim of this paper is to describe the context of alcohol use and problems in Latin America and the Caribbean (LAC), the environmental context for alcohol‐related policy, drinking trends, harm and policy and to systematically review policies implemented to reduce alcohol‐related burden.
-
Alcohol consumption, harms and policy developments in sub‐Saharan Africa: The case for stronger national and regional responses Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-02-25 Neo K. Morojele, Emeka W. Dumbili, Isidore S. Obot, Charles D. H. Parry
Sub‐Saharan Africa (SSA) has long been characterised as a region with weak alcohol policies, high proportions of abstainers and heavy episodic drinkers (among drinkers), and as a target for market expansion by global alcohol producers. However, inter‐regional analyses of these issues are seldom conducted.
-
Decline in alcohol consumption in Russia: Collectivity or polarisation? Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-02-15 Vadim Radaev, Yana Roshchina
Sales and survey data have shown a decline in alcohol consumption in Russia since 2007. This study examines whether this decline is consistent across lighter and heavier drinkers in line with the theory of the collectivity of drinking cultures.
-
The association of acute alcohol use and dynamic suicide risk with variation in onward care after psychiatric crisis Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-02-10 John E. Robins, Nicola J. Kalk, Kezia R. Ross, Megan Pritchard, Vivienne Curtis, Katherine I. Morley
Despite the association of alcohol use with recurrent suicidal acts, individuals attempting suicide after drinking alcohol face barriers accessing crisis care following emergency assessment, demonstrated by higher odds of inpatient admission for those whose suicide attempt did not feature alcohol. This disparity may be due to suicidality dissipating more rapidly after a suicide attempt involving alcohol
-
Characterising the patterns of and factors associated with increased alcohol consumption since COVID‐19 in a UK sample Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-03 Melissa Oldham, Claire Garnett, Jamie Brown, Dimitra Kale, Lion Shahab, Aleksandra Herbec
To examine changes in drinking patterns and to assess factors associated with reported increases in frequency of drinking, units consumed and frequency of heavy episodic drinking (HED) during the UK lockdown.
-
Introducing alcohol as a drug in medicine reviews with pharmacists: Findings from a co‐design workshop with patients Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-01 Mary Madden, Stephanie Morris, Margaret Ogden, David Lewis, Duncan Stewart, Ronan E. O'Carroll, Jim McCambridge
Alcohol poses a range of potential problems to people taking medications, but health professionals are usually not comfortable talking about drinking with patients. The Medicines and Alcohol Consultation aims to increase the capacity of pharmacists to conduct person‐centred reviews in which alcohol is regarded as another drug to be discussed alongside medications. This paper explores sensitivities
-
COVID‐19 vaccination among people who inject drugs: Leaving no one behind Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-01 Jenny Iversen, Amy Peacock, Olivia Price, Jude Byrne, Adrian Dunlop, Lisa Maher
Timely rollout and widespread uptake of safe and effective vaccines will be necessary to reduce mortality, improve health outcomes, restore societal well‐being and inspire economic recovery from the coronavirus disease (COVID‐19) pandemic. Unprecedented efforts to accelerate vaccine development have resulted in the emergency or expedited approval of several COVID‐19 vaccines [1]. The Australian Government
-
Examining untreated and treated alcohol problem resolution in an Australian online survey sample Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-03-01 Richard Mellor, Kari Lancaster, Alison Ritter
While treatment is an effective way to resolve alcohol problems, many people resolve their alcohol problems in the absence of treatment. Just how many do so is not known and may vary based on the definition of treatment. Various estimates of untreated alcohol problem resolution were calculated in this study, and the differences between people who resolve their alcohol problems with or without treatment
-
The longitudinal relationship between cannabis use and hypertension Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-02-28 Ahmed Haleem, Yoseob Joseph Hwang, Tara Elton‐Marshall, Jürgen Rehm, Sameer Imtiaz
The relationship between cannabis use and hypertension is not clear based on prior epidemiological studies. Thus, we examined this relationship over a 3‐year follow‐up period using a large population‐based sample from the USA.
-
Trends in treatment episodes for methamphetamine smoking and injecting in Australia, 2003–2019 Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-02-28 Rebecca McKetin, Agata Chrzanowska, Nicola Man, Amy Peacock, Rachel Sutherland, Louisa Degenhardt
We examined trends in Australian treatment episodes for smoking and injecting methamphetamine from 2003 to 2019.
-
Trends in cocaine use, markets and harms in Australia, 2003–2019 Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-02-24 Nicola Man, Agata Chrzanowska, Olivia Price, Raimondo Bruno, Paul M. Dietze, Scott A. Sisson, Louisa Degenhardt, Caroline Salom, Leith Morris, Michael Farrell, Amy Peacock
This paper aims to describe cocaine use, markets and harms in Australia from 2003 to 2019.
-
Awareness of fentanyl exposure and the associated overdose risks among people who inject drugs in a Canadian setting Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-02-18 Kanna Hayashi, Evan Wood, Huiru Dong, Jane A. Buxton, Nadia Fairbairn, Kora DeBeck, M.‐J. Milloy, Thomas Kerr
Illicitly manufactured fentanyl continues to fuel the opioid overdose crisis throughout the USA and Canada. However, little is known about factors associated with knowingly or unknowingly using fentanyl. Therefore, we sought to identify the prevalence and correlates of suspected/known and unknown exposure to fentanyl (excluding the prescribed one) among people who inject drugs (PWID), including associated
-
Communication of health risk in substance‐dependent populations: A systematic review of randomised controlled trials Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-02-09 Melvin C. W. Goh, Peter J. Kelly, Frank P. Deane, Dayle K. Raftery, Isabella Ingram
Individuals with substance use problems are at greater risk of chronic diseases due to their unhealthy lifestyle behaviours (e.g. alcohol use, smoking, physical inactivity, poor nutrition). There is increasing evidence that health risk communication is crucial in improving risk perception and knowledge of chronic diseases, and both factors are associated with health behaviour change. The aim of this
-
The efficacy of health warnings and package branding on perceptions of cannabis products among youth and young adults Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-02-04 Cesar Leos‐Toro, Geoffrey T. Fong, David Hammond
Little empirical evidence exists about the efficacy of labelling and marketing restrictions in a regulated cannabis market. This study examined perceptions of cannabis product packaging designs, health warning labels (HWL) and perceptions of packs displaying brand imagery and leading descriptors on measures of appeal, and perceived consumer attributes.
-
Non‐medical prescription opioid use and in‐hospital illicit drug use among people who use drugs Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-02-04 Gurjit S. Parmar, Kanna Hayashi, Seonaid Nolan, M.‐J. Milloy, Kora DeBeck, Hennady P. Shulha, Thomas Kerr, Lianping Ti
Illicit drug use while admitted to hospital is common amongst people who use drugs. Furthermore, non‐medical prescription opioid use (NMPOU) is increasingly being used by this population. This study was undertaken to investigate the relationship between NMPOU and having ever reported using illicit drugs in the hospital.
-
The Canadian Alcohol Policy Evaluation project: Findings from a review of provincial and territorial alcohol policies Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-02-04 Kate Vallance, Tim Stockwell, Ashley Wettlaufer, Clifton Chow, Norman Giesbrecht, Nicole April, Mark Asbridge, Russell Callaghan, Samantha Cukier, Geoff Hynes, Robert Mann, Robert Solomon, Gerald Thomas, Kara Thompson
Effective alcohol control measures can prevent and reduce alcohol‐related harms at the population level. This study aims to evaluate implementation of alcohol policies across 11 evidence‐based domains in Canada's 13 jurisdictions.
-
‘Very demanding. Extremely rewarding’: Exploring the co‐occurrence of burnout and engagement in alcohol and other drug workers Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-02-03 Natalie Skinner, Ann M. Roche
Alcohol and other drug (AOD) work can be highly meaningful and satisfying, but also intense and highly demanding. This combination often creates significant strain for workers. Mirroring this complexity, this study considered the predictors and outcomes of the concurrent experience of burnout and engagement in AOD workers. The Job Demands‐Resources model informed the study.
-
Substance use and help‐seeking among justice‐involved young people in Queensland and Western Australia: A cross‐sectional survey of 14–17‐year‐olds Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-02-02 Megan L. Steele, Carla Meurk, Jaclyn Schess, Lorraine Yap, Jocelyn Jones, Scott Harden, Sophie Davison, Tony Butler, Ed Heffernan
This study investigated substance use and help‐seeking among justice‐involved young people to inform and improve service provision during and after contact with the justice system.
-
Understanding local government responses to alcohol‐related harm Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-02-01 Miranda Guizzo, Bernadette Ward, Claire Wilkinson, Hassan Vally, Sandra Kuntsche
Local governments (LG) have a key role in reducing alcohol‐related harm, yet, Australian research investigating this is limited. This study aimed to explore Australian LGs' role in alcohol policy by investigating how LGs respond to alcohol‐related harm and what influences their responses.
-
Substance use disorder and the baby boom generation: Does Berlin outpatient addiction care face a sustained change? Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-01-28 Sara Specht, Barbara Braun‐Michl, Larissa Schwarzkopf, Daniela Piontek, Nicki‐Nils Seitz, Manfred Wildner, Ludwig Kraus
The ageing of baby boomers is expected to confront addiction care with new challenges. This cohort had greater exposure to psychoactive substances in youth than earlier cohorts. In this study, we aimed to investigate whether Berlin addiction care is confronted with a sustained change in its clientele initiated by the baby boomers.
-
Young‐adult compared to adolescent onset of regular cannabis use: A 20‐year prospective cohort study of later consequences Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-01-26 Gary C. K. Chan, Denise Becker, Peter Butterworth, Lindsey Hines, Carolyn Coffey, Wayne Hall, George Patton
This paper compares consequences of cannabis use initiated after high school with those of cannabis initiation in adolescence, with estimates of the proportion of adverse consequences accounted for by adult‐onset and adolescent‐onset cannabis users.
-
Implications of addiction diagnosis and addiction beliefs for public stigma: A cross‐national experimental study Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-01-25 Samantha M. Rundle, John A. Cunningham, Christian S. Hendershot
Stigmatisation of alcohol and other drug (AOD) use disorders poses a significant barrier to treatment access. A review by the World Health Organization concluded that addictive disorders were the most stigmatised health condition. Few studies have examined whether different etiological models of addiction (MOA) have implications for public stigma toward AOD disorders. The current study examined whether
-
How intoxicated are you? Investigating self and observer intoxication ratings in relation to blood alcohol concentration Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-01-24 Lauren A. Monds, Benjamin C. Riordan, Jayde A. M. Flett, Tamlin S. Conner, Paul Haber, Damian Scarf
The ability to accurately detect alcohol intoxication is an important skill for people who use these substances and for a variety of professions (e.g. policing, responsible service of alcohol). Previous studies have found that intoxicated people are generally poor at estimating their own intoxication (particularly at high blood alcohol concentration; BAC) and the relationship between perceived intoxication
-
Managing opioid withdrawal precipitated by buprenorphine with buprenorphine Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-01-21 Bridget Oakley, Hester Wilson, Victoria Hayes, Nicholas Lintzeris
Buprenorphine is a partial opioid agonist commonly used to treat opioid dependence. The pharmacology of buprenorphine increases the risk of a precipitated opioid withdrawal when commencing patients on buprenorphine treatment, particularly when transferring from long acting opioids (e.g. methadone). There is little documented experience regarding the management of precipitated withdrawal. In our case
-
Smokeless tobacco policy in Bangladesh: A stakeholder study of compatibility with the World Health Organization's Framework Convention on Tobacco Control Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-01-20 Eva Naznin, Olivia Wynne, Johnson George, Alexandra M. J. Denham, Mohammad E. Hoque, Abul H. Milton, Billie Bonevski, Kay Stewart
Smokeless tobacco (ST) is the predominant form of tobacco used in Bangladesh and is associated with adverse health outcomes. Bangladesh ratified the World Health Organization's Framework Convention on Tobacco Control (FCTC) in 2004. There are concerns that FCTC legislation and implementation of ST control policy is insufficient in Bangladesh. The aim of this study was to investigate the achievements
-
Alcoholic beverages in trade agreements: Industry lobbying and the public health interest Drug Alcohol Rev. (IF 2.472) Pub Date : 2020-11-12 Robin Room, Deborah Gleeson, Mia Miller
Alcohol is the only substance commonly used for intoxication that is not subject to an international agreement regulating its trade in the interest of public health and welfare [1]. Rather, it is commonly dealt with in international trade as an ordinary item of consumption and, indeed, is subject to fewer international regulations, for instance, on labelling of ingredients, than other foodstuffs [2]
-
Industry submissions on alcohol in the context of Australia's trade and investment agreements: A content and thematic analysis of publicly available documents Drug Alcohol Rev. (IF 2.472) Pub Date : 2020-11-23 Mia Miller, Claire Wilkinson, Robin Room, Paula O'Brien, Belinda Townsend, Ashley Schram, Deborah Gleeson
Alcohol use is a leading risk factor for death and disability, responsible for 3 million deaths in 2016. The alcohol industry is a powerful player in shaping trade and investment rules in ways that can constrain the ability of governments to regulate alcoholic beverages to reduce harm. This paper analyses publicly available submissions about alcohol in the context of Australia's free trade agreements
-
Using administrative health data to estimate prevalence and mortality rates of alcohol and other substance‐related disorders for surveillance purposes Drug Alcohol Rev. (IF 2.472) Pub Date : 2021-01-11 Christophe Huỳnh, Steve Kisely, Louis Rochette, Éric Pelletier, Didier Jutras‐Aswad, Alexandre Larocque, Marie‐Josée Fleury, Alain Lesage
Administrative health databases (AHD) are critical to guide health service management and can inform the whole spectrum of substance‐related disorders (SRD). This study estimates prevalence and mortality rates of SRD in administrative health databases.
-
The prospective impact of 10‐day patron bans on crime in Queensland's largest entertainment precincts Drug Alcohol Rev. (IF 2.472) Pub Date : 2020-12-27 Nicholas Taylor, Kerri Coomber, Renee Zahnow, Jason Ferris, Richelle Mayshak, Peter G. Miller
Night‐time entertainment precincts (NEP) are the site of a disproportionate amount of alcohol‐related violence, injuries and anti‐social behaviour. To combat this the Queensland government introduced patron bans in October 2014, giving police the power to exclude individuals from NEPs and preventing patrons from remaining in or entering the designated area or from designated premises for the ban duration
-
Self‐care agency and self‐care practice in youth workers reduces burnout risk and improves compassion satisfaction Drug Alcohol Rev. (IF 2.472) Pub Date : 2020-12-23 Karen T. Hallam, Danielle Leigh, Cassandra Davis, Nathan Castle, Jenny Sharples, James D. Collett
Youth work specialises in helping vulnerable young people face life challenges during critical stages of their development. It is a complex and demanding role and factors influencing occupational stress in youth workers are rarely investigated. This study examined whether youth alcohol and other drug workers with greater compassion satisfaction, self‐care practice and self‐care agency experienced different
Contents have been reproduced by permission of the publishers.